2024. FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES. CAHIERS MAGELLANES-NS. 6, 2 (Nov. 2024), 7092–7101.